Clinical Trial Update: Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating octreotide for gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber). The docum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Gastrointestinal Hemorrhage
• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Hereditary Hemorrhagic Telangiectasia, Gastrointestinal Hemorrhage | Phase 2 | Status: UNKNOWN